China expects its first-in-class new drugs to account for more than 25% of the global total by 2030, CCTV News reported today, citing the 15th Five-Year Plan for the development of the pharmaceutical industry released today. Revenue of Chinese pharmaceutical enterprises above the designated size will exceed CNY3.5 trillion (USD522 billion) by 2030.